Dr. Paul Sugarbaker discusses HIPEC in peritoneal mesothelioma

Dr. Paul Sugarbaker joined us for an interview about HIPEC (hyperthermic intraperitoneal chemotherapy) for peritoneal mesothelioma. Paul Sugarbaker, MD, FACS, FRCS, is the Chief of the Peritoneal Surface Malignancy Program and the Director of the Center for Gastrointestinal Malignancies at the Washington Hospital Center in Washington, DC. MesoTV is the Mesothelioma Applied Research Foundation’s recorded series covering pertinent conversations impacting the mesothelioma community. You can learn more at curemeso.org/mesotv. The Mesothelioma Applied Research Foundation is the only nonprofit charity organization dedicated to ending mesothelioma, and the suffering caused by this cancer, by: funding research to improve treatment options; providing treatment support and education for patients and their families; and advocating for federal funding of research.